IRIS
NICOLINI, LAURA AMBRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.143
Totale 5.143
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.143
Totale 5.143
Salva come PNG Salva come JPEG
Città #
Genova 3.356
Rapallo 621
Vado Ligure 584
Genoa 555
Bordighera 27
Totale 5.143
Salva come PNG Salva come JPEG
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 170
Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status. 160
Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: A multicenter regional simulation 155
Evaluation of insulin resistance in a cohort of HIV-infected youth. 150
Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo. 141
Implementing TB control in a rural, resource-limited setting: The stop-TB Italia project in Senegal 138
Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome. 130
Liver Enzyme Elevation During Darunavir-Based Antiretroviral Treatment in HIV-1-Infected Patients With or Without Hepatitis C Coinfection: Data from the ICONA Foundation Cohort. 129
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 119
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy 118
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients 118
Cost per care of the first year of direct antiviral agents in the liguria region: A multicenter analysis 117
Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab 117
Hepatitis B Virus Vaccination in HIV: Immunogenicity and Persistence of Seroprotection up to 7 Years Following a Primary Immunization Course 115
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 115
Tigecycline use in serious nosocomial infections: a drug use evaluation. 115
Nevirapine-based regimens in routine clinical settings: results from a large Italian cohort of HIV-1 infected adults. 114
Current status of newer carbapenems 111
Role of [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Diagnosis and Treatment of Sarcoidosis in an HIV-2-Infected Patient. 111
Successful recovery of associated interstitial nephritis and focal segmental glomerulosclerosis in patients with HCV and HIV treated with sofosbuvir and daclatasvir and revision of literature 109
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 109
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 108
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 108
Coinfection with HIV and hepatitis C virus in 229 children and young adults living in Europe 104
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 102
Visceral leishmaniasis in hematopoietic cell transplantation: Case report and review of the literature 101
Management of chronic viral hepatitis in the hematological patient 99
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 96
Weight gain: A possible side effect of all antiretrovirals 94
A global view to HBV chronic infection: Evolving strategies for diagnosis, treatment and prevention in immunocompetent individuals 92
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens 92
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 89
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: A multicentre independent study supported by the Italian Drug Agency 87
Incidence of candidaemia and relationship with flucanazole use in an intensive care unit 87
Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells 83
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing? 81
Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients 76
Long course of daptomycin in the treatment of meticillin-resistant Staphylococcus epidermis endocarditis and spondylodiscitis 76
Therapeutic management of chronic hepatitis B in clinical Practice: a region-wide survey. 75
Optimal efficacy of interferon-free HCV retreatment after protease inhibitor failure in real life 75
Correction to: Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy (Infection, 10.1007/s15010-017-1063-7) 75
Drug treatment for multidrug-resistant Acinetobacter baumannii infections 73
Rs12979860 and rs8099917 single nucleotide polymorphisms of interleukin-28B gene: simultaneous genotyping in caucasian patients infected with hepatitis C virus. 71
Ligurian Vaccination in HIV Program (LIV in HIV): the experience of Genoa metropolitan area 69
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 68
CD8+CD28-CD127loCD39+Treg Expansion: a New Pathogenic Mechanism for HIV Infection? 66
The efficacy of the new anti HCV therapy, implementation of a path based on the logic of micro-elimination in the Department of Mental Health and Addictions ASL4 Chiavarese 62
Insights on common vaccinations in HIV-infection: efficacy and safety 57
Fulminant Hepatitis Associated with Echovirus 25 during Treatment with Ocrelizumab for Multiple Sclerosis 54
Phalangeal quantitative ultrasound: cheaper methods for screening and follow-up of bone pathologies in HIV-infected women? 51
Prevalence and Risk Factors for Significant Liver Fibrosis in Patients with HIV Infection 43
HCV treatment in children and young adults with HIV/HCV co-infection in Europe 41
Comments on “Real-world re-treatment outcomes of direct-acting antiviral therapy failure in patients with chronic hepatitis C” 40
Effectiveness of first-generation HCV protease inhibitors: does HIV coinfection still play a role? 32
null 31
Barriers to HCV micro-elimination in a cohort of people living with HIV (PLWH) 28
Ten Years of Medical Informatics and Standards Support for Clinical Research in an Infectious Diseases Network 22
The second generation of HIV-1 vertically exposed infants: A case series from the Italian Register for paediatric HIV infection 19
Efficacy, safety and feasibility of treatment of chronic HCV infection with directly acting agents in hematopoietic stem cell transplant recipients – Study of infectious diseases working party of EBMT 13
Early infections after successful transcatheter aortic valve replacement are associated with increased short- and long-term mortality: A single-center study 10
Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surge 7
Totale 5.318
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.439
article - articoli 17.991
book - libri 0
conference - conferenze 448
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.878
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020998 0 0 0 0 0 162 203 120 139 218 123 33
2020/2021568 26 54 80 42 48 30 46 63 28 66 31 54
2021/2022629 28 19 34 78 25 62 23 140 54 72 24 70
2022/2023744 68 65 6 77 97 106 9 50 112 57 88 9
2023/2024432 12 51 5 50 36 94 36 34 25 8 38 43
2024/2025627 32 92 27 122 192 162 0 0 0 0 0 0
Totale 5.318